---
schema_version: "secwatch.filing_event.v1"
accession: "0001140859-26-000004"
form_type: "8-K"
ticker: "COR"
cik: "0001140859"
company_name: "Cencora, Inc."
filed_at: "2026-02-04T23:59:59+00:00"
generated_at: "2026-05-16T04:49:29.233105+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Cencora Q1 EPS $2.87 GAAP, $4.08 adjusted; acquires OneOncology for $4.6B

## Summary
- Revenue $85.9B, +5.5% YoY; GAAP diluted EPS $2.87 vs $2.50 prior year; adjusted diluted EPS $4.08 vs $3.73, +9.4%.
- Completed acquisition of OneOncology on Feb 2 for ~$4.6B in cash funded by new debt; operations consolidated in U.S. Healthcare Solutions.
- Adjusted operating income guidance raised to growth of 11.5%-13.5% from prior 8%-10%; adjusted EPS guidance reaffirmed at $17.45-$17.75.

## SEC filing metadata
- accession: 0001140859-26-000004
- form_type: 8-K
- ticker: COR
- cik: 0001140859
- company_name: Cencora, Inc.
- filed_at: 2026-02-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1140859/000114085926000004/0001140859-26-000004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1140859/000114085926000004/abc-20260202.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140859-26-000004
- JSON: https://secwatch.observer/filing/0001140859-26-000004.json
- Plain text: https://secwatch.observer/filing/0001140859-26-000004.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.